Ana Corrionero

发表

Discovery of mitogen-activated protein kinase-interacting kinase 1 inhibitors by a comprehensive fragment-oriented virtual screening approach.

O. Rabal, J. Oyarzábal, Manuel Urbano-Cuadrado, 2010, Journal of medicinal chemistry.

Hit to lead evaluation of 1,2,3-triazolo[4,5-b]pyridines as PIM kinase inhibitors.

J. Oyarzábal, J. Fominaya, N. Ajenjo, 2012, Bioorganic & medicinal chemistry letters.

Pim 1 kinase inhibitor ETP-45299 suppresses cellular proliferation and synergizes with PI3K inhibition.

J. Oyarzábal, J. Leal, J. Bischoff, 2011, Cancer letters.

β-Catenin and Plakoglobin N- and C-tails Determine Ligand Specificity*

A. G. de Herreros, M. Duñach, Ana Corrionero, 2004, Journal of Biological Chemistry.

Comparative Efficacy and Selectivity of Pharmacological Inhibitors of DYRK and CLK Protein Kinases.

L. Meijer, Ana Corrionero, M. Lindberg, 2023, Journal of medicinal chemistry.

Discovery of Novel Bruton's Tyrosine Kinase PROTACs with Enhanced Selectivity and Cellular Efficacy.

Nan Wang, P. Tonge, J. Haley, 2023, Journal of medicinal chemistry.

Synthesis and Preclinical Evaluation of a Novel Fluorine-18-Labeled Tracer for Positron Emission Tomography Imaging of Bruton's Tyrosine Kinase.

P. Tonge, Ana Corrionero, Wenchao Qu, 2023, ACS pharmacology & translational science.

Pim 1 kinase inhibitor ETP-45299 suppresses cellular proliferation and synergizes with PI3K inhibition.

J. Oyarzábal, J. Leal, J. Bischoff, 2011, Cancer letters.

β-Catenin and plakoglobin N- and C-tails determine ligand specificity.

M. Duñach, Ana Corrionero, J. Castaño, 2016, The Journal of Biological Chemistry.